(Q72862904)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

Juan Carlos García-Pagan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

R M Morillas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

R Planas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

E Cabré

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

A Galán

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J C Quer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

F Feu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

J Bosch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M A Gassull

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 December 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1502-1508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Renal effects of drugs used in the treatment of portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Hemodynamic evaluation of the patient with portal hypertension.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Measurement of azygos venous blood flow by a continuous thermal dilution technique: an index of blood flow through gastroesophageal collaterals in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Sclerotherapy vs. distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Randomized trial of portacaval shunt, stapling transection and endoscopic sclerotherapy in uncontrolled variceal bleeding

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Renal function and effective beta-blockade in cirrhosis with ascites. Relationship with baseline sympathoadrenergic tone

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis. Pharmacokinetic-hemodynamic interactions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Pharmacokinetics of intravenous and oral isosorbide-5-mononitrate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Isosorbide 5-mononitrate pharmacokinetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Specificity of Neural Effect on Renal Tubular Sodium Reabsorption

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840200620

7 January 2021

Identifiers

DOI

10.1002/HEP.1840200620

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7982651%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference